BDBM50345526 CHEMBL1784352::N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piperidin-1-ylsulfonyl)methyl)cyclopentyl)-N-hydroxyformamide::US10322143, Compound 14k

SMILES Cc1noc(C)c1CCC1CCN(CC1)S(=O)(=O)CC1(CCCC1)N(O)C=O

InChI Key InChIKey=YIKZSHOVCXXIBY-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50345526   

TargetA disintegrin and metalloproteinase with thrombospondin motifs 4(Human)
Universitetet I Oslo

US Patent
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 52nMAssay Description:Protein concentrations were measured using the Micro BCA Protein Assay Kit (Pierce/Thermo Scientific, IL). Sample buffer was mixed with 5-25 μg ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetA disintegrin and metalloproteinase with thrombospondin motifs 4(Human)
Universitetet I Oslo

US Patent
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 52nMAssay Description:Inhibition of ADAMTS-4 assessed as substrate cleavage after 16 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of ADAMTS-5 assessed as substrate cleavage after 16 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MMP-9 assessed as substrate cleavage after 20 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetMatrix metalloproteinase-14(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MMP-14 assessed as substrate cleavage after 20 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetCollagenase 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MMP-13 assessed as substrate cleavage after 20 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetInterstitial collagenase(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MMP-1 assessed as substrate cleavage after 20 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50345526(N-(1-((4-(2-(3,5-dimethylisoxazol-4-yl)ethyl)piper...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed